We are live on ! Find out more
ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
+23.37%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$280M
AUM Growth
–
Cap. Flow
+$239M
Cap. Flow %
85.54%
Top 10 Hldgs %
59.33%
Holding
170
New
170
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$36.3M
2
KROS icon
Keros Therapeutics
KROS
+$21.6M
3
ROIV icon
Roivant Sciences
ROIV
+$12.2M
4
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$6.94M
5
ABUS icon
Arbutus Biopharma
ABUS
+$6.79M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.64%
2 Technology 1.12%
3 Financials 1.12%
4 Materials 0.99%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVACU
51
DELISTED
Keen Vision Acquisition Corp Units
KVACU
$777K 0.28%
+75,000
New +$774K
THRX
52
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$708K 0.25%
+174,715
New +$533K
MRUS
53
DELISTED
Merus
MRUS
$660K 0.24%
+24,000
New +$560K
NVO
54
Novo Nordisk
NVO
$203B
$657K 0.23%
+6,350
New +$628K
GOSS icon
55
Gossamer Bio
GOSS
$87.2M
$651K 0.23%
+713,028
New +$527K
TXMD icon
56
TherapeuticsMD
TXMD
$24.2M
$612K 0.22%
+272,160
New +$657K
ZLAB icon
57
Zai Lab
ZLAB
$2.36B
$547K 0.2%
+20,000
New +$528K
TMTC
58
DELISTED
TMT Acquisition Corp Ordinary Shares
TMTC
$530K 0.19%
+50,000
New +$524K
YEAR icon
59
AB Ultra Short Income ETF
YEAR
$1.51B
$503K 0.18%
+10,000
New +$502K
PFE icon
60
Pfizer
PFE
$149B
$501K 0.18%
+17,400
New +$526K
PULS icon
61
PGIM Ultra Short Bond ETF
PULS
$18.3B
$494K 0.18%
+10,000
New +$494K
AMLX icon
62
PUT
Amylyx Pharmaceuticals
AMLX
$2.69B
$468K 0.17%
+31,800
New +$487K
GOVT icon
63
iShares US Treasury Bond ETF
GOVT
$43.5B
$461K 0.16%
+20,000
New +$445K
ABUS icon
64
CALL
Arbutus Biopharma
ABUS
$897M
$444K 0.16%
+177,700
New +$348K
GLRE icon
65
Greenlight Captial
GLRE
$511M
$389K 0.14%
+34,024
New +$379K
AKRO
66
DELISTED
Akero Therapeutics
AKRO
$374K 0.13%
+16,000
New +$316K
TSHA icon
67
Taysha Gene Therapies
TSHA
$1.82B
$370K 0.13%
+209,000
New +$417K
INDV icon
68
Indivior Pharmaceuticals
INDV
$4.56B
$368K 0.13%
+24,101
New +$428K
ONC
69
BeOne Medicines Ltd
ONC
$36.7B
$366K 0.13%
+2,028
New +$367K
VERU icon
70
Veru
VERU
$37.1M
$360K 0.13%
+50,000
New +$443K
SCRM
71
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$318K 0.11%
+30,000
New +$316K
AQN icon
72
Algonquin Power & Utilities
AQN
$4.43B
$316K 0.11%
+50,000
New +$292K
OAKU
73
DELISTED
Oak Woods Acquisition Corp
OAKU
$316K 0.11%
+30,000
New +$315K
GHIX
74
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$315K 0.11%
+30,043
New +$314K
CYTK icon
75
PUT
Cytokinetics
CYTK
$11B
$292K 0.1%
+3,500
New +$127K
1 2
3
4 5

Similar funds

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return

ADAR1 Capital Management's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for ADAR1 Capital Management, which disclosed 170 positions worth $280M. Its ten largest holdings account for 59% of the portfolio.

Its largest position is Royalty Pharma: 1,321,834 shares worth $37.1M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, followed by Technology and Financials.

  • ADAR1 Capital Management's largest Q4 2023 buy was Royalty Pharma: 1,321,834 shares worth $37.1M.
  • ADAR1 Capital Management's ten largest holdings make up 59% of its $280M portfolio in Q4 2023.
  • ADAR1 Capital Management disclosed 170 positions in Q4 2023, its first 13F filing on record.

Based on ADAR1 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.